Date Insider Type Main position Quantity % Market Cap. Importance
28/08/20 Tax

General Counsel

997 0.0007%
28/08/20 Tax

Executive/Senior Manager

281 0.0002%
28/08/20 Tax

Chief Financial Officer

256 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%-10.00% - - 3.6M
+1.96%-4.48%+46.48%+118.69% 1,206B
+0.53%+2.44%+47.10%+88.01% 665B
-0.25%+0.82%+33.14%+110.95% 515B
+2.19%+0.28%+42.81%+67.28% 381B
+0.09%-1.87%+69.95%+44.00% 362B
-0.09%+1.87%+31.10%+58.93% 307B
+0.34%+1.63%+7.31%+34.98% 289B
-1.01%-1.00%+42.36%+74.50% 249B
-0.16%-2.22%+40.43%+114.24% 207B
Average +0.38%-1.54%+40.08%+79.06% 464.42B
Weighted average by Cap. +0.75%-1.96%+42.25%+88.69%
Logo Akorn, Inc.
Akorn Inc. (Akorn), together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics. The Consumer Health segment consists of branded and private-label OTC products and animal health products dispensed by veterinary professionals. Its branded and private-label OTC products are focused on ophthalmics, including a dry eye treatment TheraTears Therapy for Your Eyes.
Employees
-
  1. Stock Market
  2. Stocks
  3. AKRXQ Stock